Author Response to Comment on: "Benefit-Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study".

Jairoun, Ammar Abdulrahman; Al-Hemyari, Sabaa Saleh; Shahwan, Moyad; Al-Qirim, Tariq; Shahwan, Monzer

Jairoun, Ammar Abdulrahman; Al-Hemyari, Sabaa Saleh; Shahwan, Moyad; Al-Qirim, Tariq; Shahwan, Monzer.

Affiliation

Jairoun AA; Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Malaysia.
Al-Hemyari SS; Health and Safety Department, Dubai Municipality, Dubai, UAE.
Shahwan M; Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Malaysia.
Al-Qirim T; Pharmacy Department, Emirates Health Services, Dubai, UAE.
Shahwan M; College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE.

Clin Med Insights Endocrinol Diabetes ; 17: 11795514241260240, 2024.

Article de En | MEDLINE | ID: mdl-38894857

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Clin Med Insights Endocrinol Diabetes Année: 2024 Type de document: Article Pays d'affiliation: Malaisie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google